Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Targeting Cognitive Function and Interoceptive Awareness to Improve Self-management in Patients With Co-morbid Heart Failure and Cognitive Impairment.

NCT05431192 is registered in ClinicalTrials.gov with The Miriam Hospital as lead sponsor.

NCT NCT05431192
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT05431192 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Targeting Cognitive Function and Interoceptive Awareness to Improve Self-management in Patients With Co-morbid Heart Failure and Cognitive Impairment.
Lead sponsor
The Miriam Hospital
Phase
Not applicable
Overall status
Active, not recruiting
Start date
November 30, 2022
Completion date
December 31, 2026
Enrollment
176 (estimated)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

cognitive impairment, heart failure